Brokerages Set Globe Life Inc. (NYSE:GL) PT at $135.60

Shares of Globe Life Inc. (NYSE:GLGet Free Report) have been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $135.60.

A number of analysts have recently issued reports on the company. Evercore ISI upgraded Globe Life from an “in-line” rating to an “outperform” rating and increased their target price for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Keefe, Bruyette & Woods raised their price objective on Globe Life from $137.00 to $145.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 12th. BMO Capital Markets assumed coverage on Globe Life in a report on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 target price on the stock. Jefferies Financial Group raised their price target on shares of Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a report on Tuesday, December 10th. Finally, Wells Fargo & Company upped their price objective on shares of Globe Life from $126.00 to $141.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th.

View Our Latest Report on GL

Insiders Place Their Bets

In related news, CEO James Matthew Darden sold 24,890 shares of Globe Life stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total value of $3,024,632.80. Following the transaction, the chief executive officer now owns 38,973 shares in the company, valued at $4,735,998.96. This trade represents a 38.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Frank M. Svoboda sold 13,448 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $112.56, for a total transaction of $1,513,706.88. Following the transaction, the chief executive officer now directly owns 18,948 shares of the company’s stock, valued at approximately $2,132,786.88. This represents a 41.51 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 61,338 shares of company stock valued at $7,239,630 over the last quarter. Insiders own 1.51% of the company’s stock.

Hedge Funds Weigh In On Globe Life

Institutional investors have recently made changes to their positions in the business. Versor Investments LP acquired a new stake in shares of Globe Life in the third quarter worth $360,000. Victory Capital Management Inc. grew its position in Globe Life by 38.9% in the 3rd quarter. Victory Capital Management Inc. now owns 421,018 shares of the company’s stock worth $44,590,000 after purchasing an additional 117,839 shares during the last quarter. CIBC Asset Management Inc increased its holdings in shares of Globe Life by 13.3% during the 3rd quarter. CIBC Asset Management Inc now owns 12,777 shares of the company’s stock worth $1,353,000 after purchasing an additional 1,495 shares during the period. Mutual of America Capital Management LLC raised its position in shares of Globe Life by 4.4% during the third quarter. Mutual of America Capital Management LLC now owns 11,060 shares of the company’s stock valued at $1,171,000 after buying an additional 471 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its position in shares of Globe Life by 4.0% during the third quarter. Thrivent Financial for Lutherans now owns 3,524 shares of the company’s stock valued at $373,000 after buying an additional 136 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.

Globe Life Price Performance

NYSE GL opened at $128.65 on Friday. Globe Life has a 1 year low of $38.95 and a 1 year high of $131.39. The business’s fifty day moving average is $122.24 and its two-hundred day moving average is $112.77. The stock has a market capitalization of $10.79 billion, a P/E ratio of 10.77 and a beta of 0.77. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05.

Globe Life (NYSE:GLGet Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. On average, research analysts forecast that Globe Life will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Thursday, April 3rd will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.84%. This is an increase from Globe Life’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Thursday, April 3rd. Globe Life’s dividend payout ratio is presently 9.04%.

Globe Life Company Profile

(Get Free Report

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.

Further Reading

Analyst Recommendations for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.